Wednesday, May, 22, 2019 01:39:18

Contribution By Ojaswita Kutepatil


Glenmark Pharma’s arm to launch a generic asthma drug in Germany

India’s leading pharmaceutical company, Glenmark Pharmaceuticals Ltd, has reportedly announced that its subsidiary has acquired the marketing authorization in Germany for Fluticasone / Salmeterol DPI (Dry Powder Inhaler). If sources are to be relied on, the product is a generic version of GlaxoSmithKline plc’s (GSK) …

Hospitals to counter rising prices by launching generic drug company

Intermountain Healthcare, headquartered in Salt Lake City, Utah, has officially announced the launch of Civica Rx, a non-profit, hospital-led generic drug company. Aimed at preventing drug shortages and cutting costs, Intermountain Health is supposedly partnering with three philanthropic groups and six other hospital systems to …

Microsoft introduces hi-tech glasses that monitor blood pressure

Software behemoth Microsoft is reportedly developing technologically advanced spectacles that incessantly monitor blood pressure all day, in a bid to reduce the risk of strokes and heart attacks. According to sources familiar with the development, these spectacles are presumed to have in-built hidden sensors at …

Alibaba unveils online service for doctor consultation, meds delivery

Alibaba, the Chinese multinational giant, has recently launched an online medical consultation and 24-hour medicine delivery service on its Taobao marketplace platform. As per sources familiar with the matter, users can now seek urgent medical attention or medications whenever required, and over-the counter medicines ordered …

Voluntis & AstraZeneca advance collaboration in the field of oncology

Voluntis, a medical intelligence firm that develops advanced digital therapeutics to enhance medications and medical devices, has reportedly announced to extend its collaboration with AstraZeneca, a multinational pharmaceutical and biopharmaceutical company, in a bid to advance oncology treatment technology. The new agreement states that the …